Sensitive Quantification of Carboxylic Acid Metabolite of Clopidogrel in Human Plasma by LC with UV Detection

A rapid LC method with UV detection was developed for the quantification of carboxylic acid metabolite of clopidogrel in human plasma. Following a simple protein precipitation using a mixture of methanolic solution of ZnSO₄, the analyte and commercially available internal standard were separated using a mobile phase of water–acetonitril (85:15, v/v) adjusted to pH 3.5 on a Chromolith C18 column at a flow rate of 2.5 mL min^?1 with a total retention time of 4 min. Linearity was verified over the range of 20–3,000 ng mL^?1 where the LOQ was 20 ng mL^?1. This method was applied in a pharmacokinetic study.     

Quantitative Determination of Phillyrin in Human Plasma Using HPLC with Fluorescence Detection

A simple, rapid, and selective high-performance liquid chromatography method for determination of phillyrin in human plasma was developed. After extracting from the plasma samples with ethyl acetate, the analyte was chromatographed on a C18 column with methanol–water (50:50, v/v, pH 2.86) as mobile phase. The fluorescence excitation and emission wavelengths were 277 and 315 nm, respectively. The linear range of the standard curve of phillyrin was 0.0313–8.0 μg mL^?1 (r > 0.999). The limit of detection was 6.31 ng mL^?1. The average recovery of phillyrin was 101.02% from plasma. The intra- and inter-day variabilities of phillyrin were <10.00%.     

Quantitative Analysis of Busulfan in Human Plasma by LC-MS–MS

High-performance liquid chromatography with tandem mass spectrometry has been used for rapid, specific, and sensitive analysis of busulfan in human plasma. Busulfan-d₈ was used as internal standard. Analysis was performed on a C₁₈ column (50 mm × 2.1 mm, 3.5-µm particles) with water–methanol 80:20 (v/v) as mobile phase at a flow-rate of 0.30 mL min⁻¹. Detection was by tandem triple–quadrupole mass spectrometry with turbo ion-spray ionization. Linear calibration plots were obtained over the concentration range 1.096–1,096 ng mL⁻¹. The assay is ideally suited to monitoring of busulfan and determination of its pharmacokinetic data.

     

Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection

A rapid, precise, accurate, and selective high-performance liquid chromatographic method with fluorescence detection has been validated and used for analysis of amisulpride in human plasma after a simple solid-phase extraction procedure. Compounds were separated on a CN column with 0.03?M potassium dihydrogen phosphate (pH 6.5)-acetonitrile 65:35 (v/v) as mobile phase. Fluorescence detection was performed at excitation and emission wavelengths of 274 and 370?nm, respectively. Calibration plots were linear over the concentration range 10-1,000?ng?mL(-1) in human plasma, and the lower limit of quantification was 10?ng?mL(-1). Accuracy was between 0.4 and 6.4% and precision was between 3.1 and 7.5%. Amisulpride was sufficiently stable through three freeze-thaw cycles, during storage for 6?h at room temperature, and for 2?months at -22?°C. The method is suitable for the analysis of clinical samples from pharmacokinetic studies.     

Determination of Amifostine and WR1065 in Rat Plasma by CE with Amperometric Detection

A method based on capillary electrophoresis with amperometric detection (CE–AD) was developed for the determination of amifostine (a cytoprotective agent, WR2721) and 2-(3-aminopropylamino)ethanethiol) (WR1065, the active metabolite of WR2721) in rat plasma. The contents of WR1065 and amifostine were determined by measuring WR1065 in deproteinized rat plasma using CE–AD before and after it was incubated at 37 °C for 4 h in acidic solution, respectively. During the incubation, amifostine was quantitatively converted to WR1065. In addition, cysteine and uric acid in rat plasma were also determined simultaneously. The detection electrode was a 500 μm diameter platinum disc electrode at a detection potential of +1.0 V (vs. saturated calomel electrode). The analytes can be well separated within 9 min in a 50-cm-long fused-silica capillary at a separation voltage of 18 kV in a 100 mM phosphate buffer (pH 7.5). The relation between peak current and analyte concentration was linear over about 3 orders of magnitude with the limits of quantification (S/N = 3) ranging from 0.60 to 1.40 μM. The method has been validated. Satisfactory within-day and between-day precisions were obtained with relative standard deviations of ≤4.9 and ≤5.1 % for WR1065 and ≤5.0 and ≤5.3 % for amifostine, respectively. The within-day and between-day accuracy was in the range of 98.6–102.3 % and 95.7–97.2 % for WR1065 and 97.5–98.6 and 95.3–97.1 % for amifostine, respectively.

     

Determination of Amifostine and WR1065 in Rat Plasma by CE with Amperometric Detection

A method based on capillary electrophoresis with amperometric detection (CE–AD) was developed for the determination of amifostine (a cytoprotective agent, WR2721) and 2-(3-aminopropylamino)ethanethiol) (WR1065, the active metabolite of WR2721) in rat plasma. The contents of WR1065 and amifostine were determined by measuring WR1065 in deproteinized rat plasma using CE–AD before and after it was incubated at 37 °C for 4 h in acidic solution, respectively. During the incubation, amifostine was quantitatively converted to WR1065. In addition, cysteine and uric acid in rat plasma were also determined simultaneously. The detection electrode was a 500 μm diameter platinum disc electrode at a detection potential of +1.0 V (vs. saturated calomel electrode). The analytes can be well separated within 9 min in a 50-cm-long fused-silica capillary at a separation voltage of 18 kV in a 100 mM phosphate buffer (pH 7.5). The relation between peak current and analyte concentration was linear over about 3 orders of magnitude with the limits of quantification (S/N = 3) ranging from 0.60 to 1.40 μM. The method has been validated. Satisfactory within-day and between-day precisions were obtained with relative standard deviations of ≤4.9 and ≤5.1 % for WR1065 and ≤5.0 and ≤5.3 % for amifostine, respectively. The within-day and between-day accuracy was in the range of 98.6–102.3 % and 95.7–97.2 % for WR1065 and 97.5–98.6 and 95.3–97.1 % for amifostine, respectively.     

Analysis of Pazufloxacin Mesilate in Human Plasma and Urine by LC with Fluorescence and UV Detection,and Its Application to Pharmacokinetic Study

A liquid chromatographic method for analysis of pazufloxacin mesilate in human plasma and urine has been developed and validated for selectivity, sensitivity, accuracy, precision, and stability in pharmacokinetic analysis. The sensitivity of the method was 0.02 μg mL^?1 in plasma and 0.5 μg mL^?1 in urine, with overall intra-day and inter-day precision (RSD < 10%) and accuracy (90–120%) acceptable for clinical pharmacokinetic analysis. Recovery from plasma and urine was 80–110% for both pazufloxacin mesilate and enoxacin, the internal standard. Pazufloxacin was stable in both plasma and urine, with no significant degradation under four different conditions. The method was successfully used in a preliminary study of the bioavailability of pazufloxacin mesilate in healthy human volunteers after intravenous administration of 300 and 500 mg.     

Voltage-Controlled Electric Field Gradient Focusing with Online UV Detection for Analysis of Proteins

Electric field gradient focusing (EFGF) uses a hydrodynamic flow and an electric field gradient to focus proteins in order of electrophoretic mobility. In this paper, we describe several bioanalytical applications using voltage-controlled hollow dialysis fiber-based EFGF with online UV detection. Using bovine serum albumin (BSA) as a model protein, a concentration factor as high as 15,000 and a concentration limit of detection as low as 30 pM were achieved. We also demonstrate the potential of using fiber-based EFGF for protein quantitative analysis. Simultaneous desalting and protein concentration were performed by mixing BSA with 2 M NaCl in a cell culture medium. Online concentration of ferritin and simultaneous removal of albumin from a sample matrix were performed using this EFGF system.     

Quantitative Determination of Busulfan in Human Plasma by UPLC

A rapid and reliable UPLC method was developed and validated for the determination of busulfan in human plasma. After protein precipitation, derivatization, and liquid–liquid extraction, separation of derivatized busulfan was achieved on an Acquity BEH C₁₈ column using a gradient mobile phase consisting of a trifluoroacetic acid aqueous solution (0.2%, v/v) and acetonitrile. The column temperature was maintained at 50 °C and UV detection was carried out at 254 nm. The complete analytical run time was 1.3 min, 7-fold faster than our previous LC methodology. Quantification was performed using external standardization and calibration curves were linear (r ≥ 0.999) over the dynamic range of 0.05–5.00 μg mL⁻¹. Intra-day and inter-day coefficients of variation were ≤6.9 and 3.9%, respectively, across the range of concentrations. Accuracy of the analytical method expressed as the relative error percentage was better than 5.4%. LOD and LOQ were 0.013 and 0.025 μg mL⁻¹, respectively. Data obtained using the UPLC method was compared to those obtained from our previously used LC method by Deming regression analysis. The UPLC method was accurate, sensitive, and greatly increased sample analysis throughput as compared to our previous LC methodology allowing for a 4-fold increase in the number of patients who could be monitored during transplant therapy.

     

Quantitative Determination of Fexofenadine in Human Plasma by HPLC-MS

A simple, rapid, sensitive and selective LC-MS method was developed and validated for quantification of fexofenadine in human plasma. The LC-MS system was operated under the positive electrospray ionisation mode (ESI). After liquid–liquid extraction, fexofenadine analysis was performed on a C₁₈ column with a mobile phase of acetonitrile: 10 mM ammonium acetate: formic acid, 70:30:0.1 (v/v/v) at a flow rate of 1 mL min⁻¹ by using loratadine as internal standard. The lower limit of quantitation was 3 ng mL⁻¹ for fexofenadine. The assay precision ranged between 1.05 and 12.56% and accuracy ranged between 82.00 and 109.07%. The validated method was successfully used to analyze human plasma samples in bioequivalence studies.

     

Enantiomeric Separation of Omeperazole Enantiomers by Aqueous CE Using UV and MS Detection

This paper details the analysis of the enantiomers of omeprazole, using aqueous CE coupled with MS detection. Following our previously published work: where a non-aqueous CE–UV method was developed for omeprazole and 5-hydroxy-omeprazole; coupling to electro-spray ionization (ESI) MS detection has now been investigated, using a sheath-flow interface for introduction. An aqueous CE method was developed and designed to afford increased compatibility with ESI–MS detection, employing an ammonium acetate buffer system (pH 5.8). Common partial filling methods could not be utilized to avoid the entrance of cyclodextrin into the MS, and therefore a modified method of non-continuous-flow CE–MS was applied, with the CE separation carried out without applied ESI voltage, before reapplying and allowing flow into the MS for data collection. A chiral CE separation of omeprazole and 5-hydroxyomeprazole was achieved, and chiral CE resolution of omeprazole has been demonstrated using MS detection.     

人血浆中游离氨基酸的离子色谱/积分脉冲安培法分析

采用离子色谱积分脉冲安培法,在AminoPae PA10色谱柱上,用250 mmol/L的NaOH溶液和1.00 mol/L的乙酸钠溶液为淋洗液分离血浆中的游离氨基酸,以Au为工作电极,pH-Ag/AgCl电极为参比电极,检测了血浆中的16种游离氨基酸,无需衍生,检出限为0.11～3.3μg/L,样品加标回收率在87%～117%范围内.     

LC with Coulometric Detection for Analysis of 5-Methyltetrahydrofolate in Human Plasma

An isocratic high-performance liquid chromatographic method with coulometric electrochemical detection has been used for analysis of 5-methyltetrahydrofolate (5-MTHF) in human plasma. A 250 mm × 4.6 mm i.d., 5-μm particle, C₁₈ column was used with 12:88 (v/v) acetonitrile ?35 mM sodium phosphate buffer pH 3.8 as mobile phase at a flow rate of 1.0 mL min^?1. The method was validated for 5-MTHF plasma concentrations in the range 2.5–100.0 nM. The method was characterized by a good linearity (regression coefficient r ≥ 0.9989) and limits of detection and quantification of 0.72 and 2.16 nM, respectively. Mean recovery at low and high concentrations ranged from 89.1 to 96.3%, respectively, with a relative standard deviation <4.6%. Between-run imprecision (4.2%) was higher than within-run imprecision (3.4%). The proposed separation and detection procedures were successfully applied to analysis of 5-MTHF in human plasma.     

Determination of Cefaclor in Human Plasma by Reversed-Phase High-Performance Liquid Chromatography with UV Detection and Its Application to the Bioequivalence Studies

Abstract

A selective and sensitive reversed-phase high-performance liquid chromatography method was developed and validated for quantitation of cefaclor in human plasma using cefradine as an internal standard. Calibration curve was linear over range of 0.1–20 mg · L^?1. The intra- and inter-run relative standard deviations of the assay were less than 7%. The mean absolute recoveries determined at the concentrations of 0.3, 3.0, 8.0, and 15.0 mg · L^?1 were 69.9%, 69.9%, 77.1% and 72.0%, respectively. The analytical method established was proved to be specific, precise, sensitive, and suitable for applying in the pharmacokinetic and bioequivalence studies of cefaclor in human.     

Quantitative Analysis of Artemether and its Metabolite Dihydroartemisinin in Human Plasma by LC with Tandem Mass Spectrometry

We report the development and validation of a high-performance liquid-chromatographic–tandem mass spectrometric method for determination of artemether (ARM) and its active metabolite dihydroartemisinin (DHA) in human plasma; artemisinin was used as internal standard (IS). Chromatographic separation was performed on a 150 mm × 4.6 mm i.d., 5 μm particle, C₁₈ column coupled with a 4.0 mm × 3.0 mm i.d., 5 μm particle, C₁₈ guard column. The mobile phase was acetonitrile–0.1% formic acid solution, 80:20 (v/v), at a flow-rate of 1 mL min^?1. An atmospheric-pressure chemical-ionization (APCI) interface was used to produce sample ions, and positive ions were quantified by using the MS detector in selected-reaction-monitoring mode, using the reaction m/z 221 to 163 for determination of ARM and DHA and the reaction m/z 283 to 219 for determination of the IS. Plasma samples were prepared by extraction with methyl t-butyl ether, evaporation of the extract to dryness, and reconstitution of the residue with mobile phase. Extraction recovery for ARM and DHA ranged from 74.74 to 99.39%. High specificity and a limit of quantification of 5 ng mL^?1 were achieved for ARM and DHA. Linearity was confirmed over the concentration range 5–500 ng mL^?1; the correlation coefficients (R) were >0.99. The relative standard deviation for intra-day and inter-day assay of both compounds was <9.60% and inaccuracy was within ±10.81%. Stock solutions were stable at 4 °C for at least 720 h. Processed extracts were stable at room temperature for at least 24 h and QC samples were stable during three freeze–thaw cycles. In spiked human plasma under ambient conditions ARM was stable for at least 8 h whereas DHA was stable for 2 h only.     

Quantification of Teicoplanin in Human Plasma by Liquid Chromatography with Ultraviolet Detection

A simple high-performance liquid chromatographic method was developed for determining five major components of teicoplanin, designated A2–1, A2–2, A2–3, A2–4 and A2–5, in human plasma. Using piperacillin sodium as internal standard, teicoplanin in plasma samples was extracted by coextractive cleanup procedure. The extracts were injected into a Nova-Pak C₁₈ column maintained at ambient temperature. The mobile phase consisted of acetonitrile–0.1% trifluoroacetic acid (27:73, pH = 2.2), at a flow rate of 1.0 mL min⁻¹. The analytes were detected at the UV wavelength of 218 nm. The method was found to be linear over the concentration range of 2.5–50 mg L⁻¹ for teicoplanin (r = 0.9993 ± 0.0038), which covered the clinically expected trough plasma levels. The percentage error of the analytical method was below 9%. The intra- and inter-day reproducibility was adequate with coefficients of variation less than 7%. The chromatographic running time was 11 min. Thus, the method can be effectively applied to measure teicoplanin concentrations in clinical samples.     

Rapid RP-LC Method with Fluorescence Detection for Analysis of Fexofenadine in Human Plasma

A rapid and sensitive reversed-phase high-performance liquid chromatographic method for analysis of fexofenadine in human plasma has been developed and optimized. The analytes were extracted from biological samples by solid-phase extraction on hydrophilic–lipophilic balance cartridges. LC separation was performed on a C₁₈ analytical column (125 mm × 4 mm i.d., 5-μm particles) with 42:58 (v/v) acetonitrile–water adjusted to pH 2.7 with 85% orthophosphoric acid as mobile phase. Fluorescence detection was performed with excitation at 230 nm and emission at 290 nm. The total time for chromatographic separation was 7 min. The method was validated in accordance with EU guidelines by analysis of plasma samples fortified with fexofenadine at concentrations between 0.05 and 800 ng mL⁻¹. Calibration plots were linear in this range. Mean recovery was typically 94.03% and the detection limit was 0.05 ng mL⁻¹. The time required for quantitative analysis is shorter than that required by other methods.

     

Simultaneous Determination of Lidocaine, Proline and Lomefloxacin in Human Urine by CE with Electrochemiluminescence Detection

A new method was developed for the simultaneous determination of lidocaine, proline and lomefloxacin in human urine by capillary electrophoresis-electrochemiluminescence detection with Ru(bpy)₃ ²⁺. Conditions of the separation and detection were investigated and optimized. It was proved that 20 mM phosphate buffer at pH 6.7 could achieve the most favorable resolution, and the high sensitivity of detection was obtained by using the detection potential at 1.15 V and 5 mM Ru(bpy)₃ ²⁺–60 mM phosphate buffer at pH 7.6 in the detection reservoir. The detection limits were 0.02 μg mL⁻¹ for lidocaine, 0.03 μg mL⁻¹ for proline and 0.06 μg mL⁻¹ for lomefloxacin. Relative standard deviations of the ECL intensity and the migration time were 3.5 and 1.1% for 6 μg mL⁻¹ lidocaine, 3.2 and 1.0% for 6 μg mL⁻¹ proline and 3.7 and 1.2% for 6 μg mL⁻¹ lomefloxacin, respectively. A baseline separation for lidocaine, proline and lomefloxacin was achieved within 360 s. The developed method was successfully applied to determine the amounts of lidocaine, proline and lomefloxacin in human urine. The recovery and RSD were in the range of 93.3–97.2 and 3.8–4.9%, respectively.     

Rapid RP-LC Method with Fluorescence Detection for Analysis of Fexofenadine in Human Plasma

A rapid and sensitive reversed-phase high-performance liquid chromatographic method for analysis of fexofenadine in human plasma has been developed and optimized. The analytes were extracted from biological samples by solid-phase extraction on hydrophilic–lipophilic balance cartridges. LC separation was performed on a C₁₈ analytical column (125 mm × 4 mm i.d., 5-μm particles) with 42:58 (v/v) acetonitrile–water adjusted to pH 2.7 with 85% orthophosphoric acid as mobile phase. Fluorescence detection was performed with excitation at 230 nm and emission at 290 nm. The total time for chromatographic separation was 7 min. The method was validated in accordance with EU guidelines by analysis of plasma samples fortified with fexofenadine at concentrations between 0.05 and 800 ng mL^?1. Calibration plots were linear in this range. Mean recovery was typically 94.03% and the detection limit was 0.05 ng mL^?1. The time required for quantitative analysis is shorter than that required by other methods.     

Analysis of Non-Aromatic Organic Acids in Beer by CE and Direct Detection Mode with Diode Array Detection

A method for the analysis of the main non-aromatic organic acids in beer using capillary electrophoresis is presented. In this work, malic, citric, succinic, pyruvic, acetic and lactic acids are separated using a sodium hydrogen phosphate background electrolyte with direct detection mode with a diode array detector. The separation exhibits lower sensitivity than equivalent methods with indirect detection mode, however, the risk of co-migration with unknown compounds in beer matrixes is significantly reduced. This is due to (i) a higher efficiency (250,000–400,000 theoretical plates), (ii) a higher selectivity than any equivalent method using an indirect detection mode, and (iii) the possibility to monitor other wavelengths in parallel (260 nm for example) to check for possible co-migration with phenolic or benzoic acids. This was critical when working with beer samples as an unknown compound absorbing at 200 and 260 nm was detected in the neighbourhood of malic, citric and succinic acids. Such co-migration will not have been detected using single wavelength detection below 200 nm or indirect detection mode.